Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab
European Journal of Ophthalmology, 07/03/2012
Clinical Article
Wittstrom E et al. – This study suggests that intravitreal injection of bevacizumab is valuable in the treatment of neovascular glaucoma (NVG) by hastening the resolution of neovascularization, while the full–field electroretinography results indicate that bevacizumab may reduce the photoreceptor function in NVG patients.



